Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
5026
DELISTED
PotlatchDeltic
PCH
| $41K | ﹤0.01% |
1,438
-522
| -27% | -$17.5K |
|
5027
QuinStreet
QNST
$898M
| $41K | ﹤0.01% |
8,058
-623
| -7% | -$3.65K |
|
5028
Strategic Education
STRA
$1.89B
| $41K | ﹤0.01% |
758
+533
| +237% | +$27.3K |
|
5029
Tucows
TCX
$162M
| $41K | ﹤0.01% |
1,800
-600
| -25% | -$15.6K |
|
|
ERF
5030
PUT
DELISTED
Enerplus Corporation
ERF
| $41K | ﹤0.01% |
10,200
-19,500
| -66% | -$124K |
|
|
LORL
5031
DELISTED
Loral Space and Communications, Inc.
LORL
| $41K | ﹤0.01% |
870
-2,673
| -75% | -$158K |
|
|
IMMU
5032
CALL
DELISTED
Immunomedics Inc
IMMU
| $41K | ﹤0.01% |
41,500
-127,300
| -75% | -$325K |
|
5033
PUT
Angi Inc
ANGI
$251M
| $40K | ﹤0.01% |
800
| – | – |
|
5034
PUT
St. Joe Company
JOE
$3.69B
| $40K | ﹤0.01% |
2,100
-100
| -5% | -$1.7K |
|
5035
PUT
Keurig Dr Pepper
KDP
$42.3B
| $40K | ﹤0.01% |
500
+400
| +400% | +$31.4K |
|
|
LADR
5036
Ladder Capital
LADR
$1.22B
| $40K | ﹤0.01% |
3,504
+2,308
| +193% | +$29.1K |
|
5037
PUT
Navient
NAVI
$880M
| $40K | ﹤0.01% |
3,600
| – | – |
|
5038
CALL
RPC Inc
RES
$1.31B
| $40K | ﹤0.01% |
5,000
+4,400
| +733% | +$50.2K |
|
5039
iShares MSCI Turkey ETF
TUR
$214M
| $40K | ﹤0.01% |
1,106
-461
| -29% | -$18.4K |
|
5040
CALL
VEON
VEON
$3.76B
| $40K | ﹤0.01% |
400
-60
| -13% | -$7.5K |
|
5041
Vanguard Morningstar Growth ETF
VUG
$230B
| $40K | ﹤0.01% |
2,370
| – | – |
|
|
XONE
5042
PUT
DELISTED
The ExOne Company
XONE
| $40K | ﹤0.01% |
6,700
-4,800
| -42% | -$39.8K |
|
5043
CALL
Amkor Technology
AMKR
$13.9B
| $39K | ﹤0.01% |
9,800
-1,700
| -15% | -$8.36K |
|
5044
CALL
American Superconductor
AMSC
$1.62B
| $39K | ﹤0.01% |
9,700
+3,000
| +45% | +$14.1K |
|
5045
PUT
Clean Harbors
CLH
$16.4B
| $39K | ﹤0.01% |
900
-3,800
| -81% | -$189K |
|
5046
CALL
Compass Minerals
CMP
$1.25B
| $39K | ﹤0.01% |
500
-500
| -50% | -$41K |
|
5047
Heritage Financial
HFWA
$1.25B
| $39K | ﹤0.01% |
2,190
+412
| +23% | +$7.45K |
|
5048
iShares Morningstar Small-Cap Value ETF
ISCV
$710M
| $39K | ﹤0.01% |
1,080
| – | – |
|
5049
MillerKnoll
MLKN
$1.66B
| $39K | ﹤0.01% |
1,370
-856
| -38% | -$24.1K |
|
5050
Tetra Tech
TTEK
$8.97B
| $39K | ﹤0.01% |
8,210
-4,945
| -38% | -$25.3K |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.